Third Harmonic Bio Inc. Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
2021
2020
0M
-
0M
0M
44M
20M
24M
-44M
0M
-31M
0M
-31M
-18.26%
44M
13M
-44M
0M
-44M
0M
-
0M
0M
38M
13M
24M
-38M
3M
-35M
0M
-38M
27.35%
38M
3M
-40M
0M
-38M
0M
-
0M
0M
19M
3M
16M
-19M
11M
-30M
0M
-30M
131.19%
19M
0M
-30M
0M
-19M
0M
-
0M
0M
11M
1M
10M
-11M
0M
-13M
0M
-13M
131.19%
11M
0M
-11M
0M
-11M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
4Q2021
3Q2021
2Q2021
1Q2021
0M
-
0M
0M
10M
4M
6M
-10M
0M
-7M
0M
-7M
-49.96%
10M
4M
-10M
0M
-10M
0M
-
0M
0M
11M
5M
6M
11M
0M
7M
0M
7M
-185.50%
11M
3M
11M
0M
11M
0M
-
0M
0M
11M
5M
5M
-11M
0M
-8M
0M
-8M
-0.12%
11M
3M
-11M
0M
-11M
0M
-
0M
0M
12M
5M
7M
-12M
3M
-9M
0M
-12M
54.07%
12M
0M
-12M
0M
-12M
0M
-
0M
0M
14M
4M
9M
-14M
2M
-11M
0M
-14M
-13.45%
14M
0M
-14M
0M
-14M
0M
-
0M
0M
9M
4M
5M
-9M
0M
-8M
0M
-9M
16.35%
9M
0M
-9M
0M
-9M
0M
-
0M
0M
8M
4M
4M
-8M
0M
-8M
0M
-8M
16.35%
8M
0M
-8M
0M
-8M
0M
-
0M
0M
8M
2M
6M
-8M
0M
-8M
0M
-8M
16.35%
8M
0M
-8M
0M
-8M
0M
-
0M
0M
6M
1M
4M
-6M
0M
-16M
0M
-16M
16.35%
6M
0M
-6M
0M
0M
0M
-
0M
0M
6M
1M
5M
-6M
0M
-7M
0M
-7M
16.35%
6M
0M
-6M
0M
-6M
0M
-
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
16.35%
0M
0M
0M
0M
-4M
0M
-
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
16.35%
0M
0M
0M
0M
-4M